Home/Filings/4/0001968202-24-000107
4//SEC Filing

LAROSA JOSEPH J 4

Accession 0001968202-24-000107

CIK 0000872589other

Filed

Jul 11, 8:00 PM ET

Accepted

Jul 12, 4:00 PM ET

Size

5.4 KB

Accession

0001968202-24-000107

Insider Transaction Report

Form 4
Period: 2024-07-11
LAROSA JOSEPH J
SVP Gen Counsel and Secretary
Transactions
  • Sale

    Common Stock

    2024-07-11$1088.95/sh1,866$2,031,98137,937 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    371
Footnotes (1)
  • [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 16, 2024.

Issuer

REGENERON PHARMACEUTICALS, INC.

CIK 0000872589

Entity typeother

Related Parties

1
  • filerCIK 0001238303

Filing Metadata

Form type
4
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 4:00 PM ET
Size
5.4 KB